At the 4-week mark, the first dose increase typically occurs (from 0.25 mg to 0.5 mg on Ozempic/Wegovy), which can temporarily restart GI symptoms
Reviewed by: Katelyn O'Brien, PharmD, BCPS, CDCES Clinical Pharmacy Specialist, Boston Medical Center
And this sentiment is now driving innovation in the frozen dessert aisle
Typical research escalation follows a pattern similar to pharmaceutical guidelines, starting at 0.25mg weekly for the first four weeks, increasing to 0.5mg weekly for the next four weeks, and then to 1.0mg weekly for maintenance, with some protocols escalating further to 2.4mg weekly
These criteria are narrower than the general obesity indication that many commercial plans previously covered